K. Gálvez

Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma

K. Gálvez, 2019, Innovative Journal of Medical and Health Science.

Real-World Evidence of Epidemiology and Clinical Outcomes in Multiple Myeloma, Findings from the Registry of Hemato-Oncologic Malignancies in Colombia, Observational Study.

C. Sossa, A. Peña, M. Mateos, 2021, Clinical lymphoma, myeloma & leukemia.

Thrombotic thrombocytopenic purpura Description of diagnosis and management of a rare entity with a high mortality

J. Combariza, K. Gálvez, A. Benjumea, 2012 .

Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study

C. Sossa, G. Remaggi, G. Machnicki, 2019, Journal of global oncology.

Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma.

N. Puig, M. Boccadoro, R. Hájek, 2021, Future oncology.

[Adequate diagnosis of acquired hemophilia A].

K. Gálvez, Claudia Agudelo Lopez, Claudia Patricia Casas Patarroyo, 2019, Revista medica de Chile.

A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia

H. Misra, A. Abuchowski, K. Gálvez, 2016, Revista brasileira de hematologia e hemoterapia.